Dyne Therapeutics Inc (DYN)
24.80
+0.17
(+0.69%)
USD |
NASDAQ |
Apr 17, 16:00
24.80
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Accounts Payable (Quarterly): 22.94M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.94M |
| September 30, 2023 | 3.553M |
| June 30, 2023 | 2.724M |
| March 31, 2023 | 8.77M |
| December 31, 2022 | 5.259M |
| September 30, 2022 | 0.919M |
| June 30, 2022 | 6.972M |
| March 31, 2022 | 5.188M |
| Date | Value |
|---|---|
| December 31, 2021 | 4.031M |
| September 30, 2021 | 7.088M |
| June 30, 2021 | 5.649M |
| March 31, 2021 | 5.76M |
| December 31, 2020 | 3.44M |
| September 30, 2020 | 1.488M |
| June 30, 2020 | 2.192M |
| December 31, 2019 | 1.256M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.919M
Minimum
Sep 2022
22.94M
Maximum
Dec 2023
5.452M
Average
4.610M
Median
Accounts Payable (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | -- |
| Solid Biosciences Inc | 2.032M |
| Avidity Biosciences Inc | 8.809M |
| Sana Biotechnology Inc | 4.108M |
| Tenaya Therapeutics Inc | 5.63M |